[Carboplatin/epirubicin/prednimustine (Sterecyt) as an adjuvant chemotherapy combination in ovarian cancer treated by radical surgery].
Pickel
H
H
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016190:Carboplatin; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007044:Hysterectomy; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000601:surgery; D010052:Ovariectomy; D011238:Prednimustine / Q000008:administration & dosage; D012189:Retrospective Studies
D009944:Organoplatinum Compounds; D015251:Epirubicin; D004317:Doxorubicin; D003520:Cyclophosphamide; D011238:Prednimustine; D016190:Carboplatin; D002945:Cisplatin
Carboplatin/Epirubicin/Prednimustin (Sterecyt) als adjuvante Chemotherapie-Kombination beim radikal operierten Ovarialkarzinom.